Skip to content
JournalsWorldThe Global Research Discovery Platform
SCHOLARLY PUBLICATION ✓ Open Access

C3 glomerulopathy: consensus report

Matthew Caleb Pickering, Vivette Denise D’Agati, Carla Nester, Richard J. Smith, Mark Haas, Gerald B. Appel, Charles E. Alpers, Ingeborg M. Bajema, Camille L. Bedrosian, Michael Braun, Mittie K. Doyle, Fádi Fakhouri, Fernando Custodio Fervenza, Agnes B. Fogo, Véronique Frémeaux‐Bacchi, Daniel Philip Gale, Elena Goicoechea de Jorge, Gene Griffin, Claire Louise Harris, V. Michael Holers, Sally Ann Johnson, Peter Lavin, Nicholas Medjeral‐Thomas, B. Paul Morgan, Cynthia C. Nast, Laure‐Hélène Noël, D. Keith Peters, Santiago Rodrı́guez de Córdoba, Aude Servais, Sanjeev M. Sethi

📄 Abstract

C3 glomerulopathy is a recently introduced pathological entity whose original definition was glomerular pathology characterized by C3 accumulation with absent or scanty immunoglobulin deposition. In August 2012, an invited group of experts (comprising the authors of this document) in renal pathology, nephrology, complement biology, and complement therapeutics met to discuss C3 glomerulopathy in the first C3 Glomerulopathy Meeting. The objectives were to reach a consensus on: the definition of C3 glomerulopathy, appropriate complement investigations that should be performed in these patients, and how complement therapeutics should be explored in the condition. This meeting report represents the current consensus view of the group.

📤 Share this page

Found this useful? Share it with your network.

✓ Link copied! Paste it on ResearchGate / Academia.edu